Literature DB >> 6349923

Pharmacologic models of anxiety.

L B Guttmacher, D L Murphy, T R Insel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349923     DOI: 10.1016/0010-440x(83)90059-7

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


× No keyword cloud information.
  12 in total

Review 1.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

2.  FG 7142 and its anxiety-inducing effects in humans.

Authors:  R Dorow
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  States of anxiety and their induction by drugs.

Authors:  M Lader; M Bruce
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

4.  Long-term effects of yohimbine on behavioral sensitivity to a stressor.

Authors:  T L Davidson; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.

Authors:  Peter Zwanzger; Rainer Rupprecht
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

Review 6.  Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.

Authors:  David S Baldwin; Ruihua Hou; Robert Gordon; Nathan T M Huneke; Matthew Garner
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

7.  Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.

Authors:  H Pols; E Griez; K Verburg; D van der Werf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

8.  Dose ranging study of the effects of cholecystokinin in healthy volunteers.

Authors:  J Bradwejn; D Koszycki; M Bourin
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

9.  Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

Authors:  M Albus; T P Zahn; A Breier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 10.  Neurobiological investigations into the role of cholecystokinin in panic disorder.

Authors:  J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.